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ABSTRACT:  
Biocides, primarily those containing quaternary ammonium compounds (QAC), are 
heavily used in hospital environments, and various industries (food, water, cosmetic, 
etc). To date, little attention has been paid to potential implications of QAC use in the 
emergence of antibiotic resistance, especially fluoroquinolone-resistant bacteria in 
patients and in the environment. QAC-induced overexpression of efflux pumps can 
lead to: i) cross-resistance with fluoroquinolones mediated by multidrug efflux pumps; 
ii) stress response facilitating mutation in the Quinolone Resistance Determining 
Region; iii)  biofilm formation increasing the risk of transfer of mobile genetic 
elements carrying fluoroquinolone or QAC resistance determinants. By following the 
European Biocidal Product Regulation, manufacturers of QAC are required to ensure 
that their QAC-based biocidal products are safe and will not contribute to emerging 
bacterial resistance.  
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Quaternary ammonium compounds (QAC) are among the most commonly 
used disinfectants in a number of fields of applications (Table 1) [1-3]. Over the past 
decade there has been a dramatic increase in the use of QAC: In Europe, in 2006, 
the market for biocides amounted to €10-11 billion, with an average growth of 4-5% 
per annum during the previous 15 years, and market expansion is predicted to 
continue (http://www.pan-europe.info/campaigns/biocides). QAC are now commonly 
found in consumer products, such as washing liquid, home surface disinfectant, 
toiletries, in Western Europe and North America. The main QAC currently used are 
benzalkonium chloride (BC), stearalkonium chloride, and didecyldimethylammonium 
chloride (DDAC) (Table 2) [3-5]. Their impact may not be limited to their area of use, 
as QAC ultimately reach the environment via waste water and may remain there for a 
long time, due to their poor biodegradability [6,7]. In Europe, the European Biocidal 
Product Regulation [8] states in several articles that the possible effect of a biocidal 
product on developing resistance and cross-resistance in bacteria needs to be 
evaluated. Evidence of bacterial developing antimicrobial resistance following the use 
of biocide was reviewed by the Scientific Committee on Emerging and Newly 
Identified Health Risks [9], and more recently by Maillard et al. [10]. There are a 
number of definitions of bacterial ‘resistance’, to biocides. The following definition has 
been proposed: “‘a change in susceptibility to a microbicide that renders it ineffective 
against a micro-organism that was previously susceptible to that microbicide’ [10], but 
this definition does not necessarily apply to the existing literature that is cited in this 
review. A number of papers are defining resistance to QAC as an increase in MIC, 
although this should now be viewed as a reduced susceptibility [10]. 
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 Fluoroquinolones (FQ) are potent broad-spectrum antibiotics that have been 
used in medical practice for the treatment of severe or resistant bacterial infections 
since the late 1980s. As their name suggests, they are derived from the quinolone 
family of antibiotics; quinolones themselves are synthetic constructs, developed by 
modification of 1-alkyl-1,8-naphthyridin-4-one-3-carboxylic acid [11]. 
Fluoroquinolones differ from quinolones by the replacement of the eighth carbon 
atom of the backbone with a nitrogen atom and the addition of a fluorine atom at the 
sixth position, giving them more potent antibiotic action and a broader spectrum of 
activity [12]. FQ are potent inhibitors of bacterial type II topoisomerases, which are 
essential enzymes involved in key cellular processes, including DNA replication [13-
15]. Their spectrum of efficacy against a wide range of Gram-positive and Gram-
negative pathogenic bacteria has led to their widespread use worldwide [16]. Yet, 30 
years after their introduction, resistance levels have dramatically increased worldwide 
[17].  
 
All bacteria have multidrug transporters or bacterial drug efflux pumps 
inserted into the cytoplasmic membrane that can remove toxic substances from the 
cytoplasm and from the cytoplasmic membrane [18]. The major clinically relevant 
efflux systems in Gram-negative bacteria belong to the resistance-nodulation-division 
(RND) superfamily (e.g. AcrAB-TolC in Escherichia coli, Mex-OPr in Pseudomonas 
aeruginosa), and are typically composed of a cytoplasmic membrane pump, a 
periplasmic protein and an outer membrane protein channel [19]. In the case of 
Gram-positive bacteria, the major facilitator superfamily (MFS; e.g., Bmr and Blt in 
Bacillus subtilis and NorA in Staphylococcus aureus), and the ATP-binding cassette 
(ABC) transporters are major players [19]. These efflux pumps can remove various 
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antibiotics and are then called multidrug resistance (MDR) pumps [18,20,21]. The 
regulation of efflux pump genes is complex and controlled by both dedicated 
regulators and multiple global regulators, which also control expression of other 
genes [22].  
Commonalities exist regarding the concomitant use of FQ and QAC in 
industrial and hospital environments, and in both cases, resistance to FQ is 
increasing. In agribusiness, FQ are administered to treat infections in animals, and 
QAC are used as surface disinfectants in farms and in processing plants. In hospitals, 
QAC are used as surface disinfectant, and FQ is among the first two classes in terms 
of antibacterial agent consumption, second only to beta-lactams. QAC and FQ can 
persist in various environments. They have been detected in sewage sludge, river 
water and soil [23-25]. Class 1 integrons encoding efflux pumps were identical in 
clinical samples [26-28] and those isolated from soil and freshwater biofilms. The 
efflux pumps play an important role in increasing MICs, both for QAC that FQ, and 
the hazard/risk of biocide use leading to the selection of antibiotic-resistant bacteria 
and their dissemination is of increasing concern 
(http://ec.europa.eu/health/opinions/en/biocides-antibiotic-resistance/l-3/1-definition-
antimicrobials.htm). In the meantime, WHO developed a list ranking antimicrobial 
classes according to their importance for public health. Fluoroquinolones were 
viewed as one of the highest priority for risk analysis [29]. 
The aim of this review was to present documented interactions between the 
use of QAC and the emergence of fluoroquinolone resistance in bacteria, focusing on 
three main pathways: i) “cross-resistance” of QAC and FQ mediated by multidrug 
efflux pumps, ii) QAC-induced stress responses that trigger mutation in the quinolone 
resistance-determining region (QRDR) and iii) synergistic effect on biofilm formation, 
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facilitating the transfer of mobile genetic elements carrying FQ or QAC resistance 
determinants. 
 
 Cross-resistance of QAC and FQ mediated by multidrug efflux pumps  
Overexpression of efflux pumps is hypothesised to mediate cross-resistance of 
FQ and QAC [30]. QAC can directly induce the expression of efflux pumps, or 
promote mutations within the regulators of efflux pump genes (Figure 1) [31-37]. 
Indeed, some strains carrying specific mutations at target sites are no longer 
resistant to FQ if efflux pumps are inactivated [38-40]. Efflux pumps may also play a 
role in the impact of mutations. Oethinger et al. showed that in the absence of the 
AcrAB efflux pump, topoisomerase mutations had no significant impact on FQ 
resistance in E. coli [38]. 
In Gram-negative bacteria, two of the best-studied RND-type MDR-pump 
systems are AcrAB-TolC or OqxAB in E. coli, SdeXY of S. marcescens, and Mex-Opr 
[20], and PmPM pumps in P. aeruginosa, MepA and NorA of S. aureus  (Figure 2) 
[24,41-47]. In E. coli, AcrAB-TolC is present in wild-type bacteria, and its 
overexpression induces resistance to quinolones and QAC, as outlined below. Buffet-
Bataillon et al. [48] observed an epidemiological association between high minimal 
inhibitory concentrations (MICs) of QAC and antibiotic resistance, without previous 
exposure to QAC. The efflux pump inhibitor phenyl-arginine-b-naphthylamide (PAbN) 
reduced the MICs of ciprofloxacin (CIP) and QAC, but remained ineffective in 
reducing the MIC of others antibiotics tested [48]. In this work, AcrAB-TolC system 
explained the association between resistance to FQ and QAC.  Other works showed 
the induction of various efflux pumps in Gram-negative bacteria by antibiotics or by 
QAC [30,49-53]. For example, Serratia marcescens gained resistance to 
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cetylpyridinium chloride, BC and antibiotics by expressing the SdeAB efflux pump 
upon exposure to cetylpyridinium chloride [51]. In P. aeruginosa, primary intrinsic 
resistance to FQ is due to MexAB-OprM as well as to MexXY-OprM [53]. The RND-
type MexCD-OprJ multidrug efflux pump is induced by norfloxacin and by ADBAC 
[49]. In P. aeruginosa, ADBAC, FQ, ethidium bromide, and tetraphenylphosphonium 
chloride were all substrates for PmpM, a multidrug efflux pump belonging to the 
Multidrug and Toxic Compound Extrusion (MATE) family [50]. An active role of efflux 
pump activity in conferring adaptive and cross resistances against CIP and BC has 
been shown in P. aeruginosa isolated from food products [30]. Burkholderia cepacia 
developed stable tolerance to benzethonium chloride with cross-resistance to FQ, 
associated with enhanced efflux, reduced swarming mobility and increased biofilm 
formation [52].  Recently, Webber et al. [54] exposed Salmonella enterica serovar 
Typhimurium to biocides and showed mutations in ramR, which encodes the local 
repressor of ramA, encoding a transcriptional activator that regulates the AcrAB-TolC 
MDR efflux system. 
The same observations were made with Gram-positive bacteria, including 
Listeria monocytogenes, a major agent for severe food-borne illness, or 
Staphylococcus aureus, an important cause of nosocomial infections. Mutations in 
efflux systems of L. monocytogenes strains are responsible for the multidrug 
resistance phenotype of strains selected on CIP or ADBAC [55]. Other authors also 
observed that reduced susceptibility to biocides in staphylococci was associated with 
quaternary ammonium compound (qac) gene-encoding efflux proteins (qacA, qacB, 
qacC, qacG) [56,57].  
However, if many studies are in accordance with the concept of cross-
resistance to QACs and FQ, others are not so supportive. Furi et al. [57] showed that 
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9.5% of clinical isolates of S. aureus carried known genes associated with ethidium 
bromide efflux pump and reduced susceptibility to biocides. Fine characterization of 
the substrate specificity of these pumps associated (i) mutations of the promoter 
region of norA with a 2-fold increase in MIC to BC, (ii) the presence of the plasmid-
encoded MFS pumps QacA and QacB with a 4-fold increase in MIC of BC, and (iii) 
the plasmid-encoded SMR efflux pumps QacC and QacG with a 2-fold increase in 
MIC to BC. Regarding cross-resistance to antibiotics in vitro, mutation of the norA 
promoter conferred cross-resistance to CIP and norfloxacin (NOR), but not all clinical 
isolates with norA promoter mutations were resistant to CIP, and none of the plasmid 
encoded efflux pumps conferred resistance to antibiotics. Such a study highlights the 
importance of future clinical work to validate these experiments.  
 
 Stress responses that trigger mutation in the quinolone resistance-
determining region (QRDR)  
 FQ target DNA gyrase and topoisomerase IV in a broad range of bacteria, by 
inhibiting their control of supercoiling within the cell, resulting in impaired DNA 
replication (at lower concentrations) and cell death (at lethal concentrations) [58,59]. 
An important mechanism of bacterial resistance to FQ is due to mutation(s) in one or 
more of the genes that encode the primary and secondary targets of these drugs, 
type II topoisomerases (gyrA, gyrB, parC, and parE). The region where mutations 
arise in these genes that encode FQ resistance is a short DNA sequence known as 
QRDR [60,61]. Mutations in QRDR, resulting in amino acid substitutions, alter the 
target protein structure and subsequently the FQ binding affinity of the enzyme, 
leading to drug resistance [16,62]. Recently, Weber et al. [54] described that 
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Salmonella enterica serovar Typhimurium to QAC and selected antibiotic-resistant 
mutants: genes in the QRDR region (gyrA) and in rpoA, encoding the RNA 
polymerase alpha subunit, were altered [54].  
The SOS response is an inducible pathway governing DNA repair. Two key 
proteins govern the SOS response: LexA (a repressor) and RecA (an inducer). Whilst 
the SOS response was initially recognised as regulating DNA damage repair, its 
broader role is now well established. The SOS error-prone polymerases that enable 
translation and DNA synthesis also promote an elevated mutation rate that generates 
genetic diversity and adaptation, hence facilitating the emergence of antibiotic 
resistance [63,64]. QAC are strong cationic surface-active chemicals and could be 
hypothesised to trigger a SOS response following their physical interaction with the 
bacterial membrane. However, there are no studies that have directly investigated at 
effect of QAC and bacterial SOS response. Ceragioli et al. [65] reported that Bacillus 
cereus, upon exposure to selected concentrations of BC (0.5 to 7 mg/L), induced 
genes involved in the general and oxidative stress responses.  Although this study 
did not look directly at SOS response, others have observed that exposure to 
oxidative stress can activate the SOS response [66]. A better evidence of the direct 
effect of QAC exposure on SOS response is needed. 
If QAC are indeed significant triggers of the SOS response, this would 
increase mutation rates, which may promote the emergence of mutations in 
topoisomerases. However, these assumptions are not supported by robust scientific 
evidence to date, except on that of McCay et al. [67], who described a P. aeruginosa 
mutant highly adapted to ADBAC with an increased resistance to CIP (0.125 to 32 
mg/L) in 33 generations elapsed in culture enrichment. This was due to mutations in 
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QRDR of gyrA and in genes mexR and nfxB that encode repressors of mexAB-oprM 
and mexCD-oprJ, respectively.  
 
 The impact of QAC on efflux pumps, SOS responses, and biofilm formation, 
may facilitate the transfer of mobile genetic elements carrying FQ or QAC 
resistance determinants between bacteria 
Recent research showed that QAC, efflux pumps expression and biofilm 
formation are connected processes [68-70] (Figure 1). QAC have been shown to 
induce expression of efflux pumps [31-37]. Baugh et al. demonstrated that both 
genetic inactivation and chemical inhibition of efflux pumps resulted in transcriptional 
repression of genes involved in biofilm matrix production, leading to biofilm formation 
inhibition [62]. Similarly, a significant increase of efflux pump activity was observed 
with changes in their biofilm formation potential [68]. Pagedar et al. [68] 
demonstrated that QAC can trigger biofilm formation, highlighting the role of adaptive 
response to FQ and BC. These findings provided an insight into the process of 
conversion from non-resistant to resistant isolates in parallel with biofilm formation 
following adaptation to antimicrobial agent exposure [68]. Ebrahimi et al. [71] 
documented the effects of BC on planktonic growth and biofilm formation in E. coli, 
Salmonella sp., S. aureus, and Streptococcus agalactiae, and found that in all the 
bacteria tested biofilm formation increased with decrease of BC concentration. These 
results were confirmed for L. monocytogenes exposed to disinfectants such as BC, 
which are commonly used to control contamination in food processing plants. 
However, Ortiz et al. [72] also showed that effect of sub-MIC of BC on biofilm 
production by L. monocytogenes might differ between strains with different MICs, and 
even between resistant strains with similar MICs but different genetic determinants of 
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BC resistance. One of the mechanisms involved in reducing biofilm susceptibility to 
antimicrobials is the presence of bacterial persisters [73]. The AcrAB-TolC MDR 
efflux pump has been shown to lower the intracellular concentration of FQ in E. coli, 
and to increase the level of surviving persisters and their tolerance to FQ [74]. Stress 
responses may also act as general activators of persister formation, via the toxin-
antitoxin system TisB, inducing the entry of bacteria into dormancy [70,74]. Although 
QAC can trigger efflux and cause bacterial stress, there is a need for studies showing 
a direct link between QAC exposure and increased levels of persisters in bacterial 
biofilms.  
 
 Several studies have also demonstrated that biofilm formation and 
horizontal gene transfer are connected processes.  
Interrelations between QAC, efflux pump expression and biofilm formation, 
were described above.  Madsen et al. [75] also reviewed the relationship between 
biofilm formation and horizontal gene transfer. Biofilms can enhance the host range 
of mobile genetic elements carrying FQ resistance determinants that are transferred 
horizontally [75], or qac gene cassettes [76].  Horizontal gene transfer can occur by 
conjugation, transformation or transfection, through mobile genetic elements 
(integrons), or plasmids. Both conjugative plasmid DNA transfer and transformation 
induce the SOS response [77-79]. Whereas both conjugation and transformation 
induce the SOS response, the latter also activates integrase genes involved in DNA 
transfer and recombination [80]. Integrons are genetic elements capable of 
integrating genes by a site-specific recombination system catalysed by an integrase 
and class 1 integron incidence was shown to be significantly higher for populations 
that were preexposed to QACs [81,82]. Guérin et al. [83] found that LexA controlled 
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expression of most integrases and consequently regulated cassette recombination 
[83].  Gaze et al. [84] propose that the integration of gene cassettes conferring 
resistance to FQ agents within integrons can be only a matter of time. 
The integrating genes are exogenous genes, including qnr, aac(60)-lb-cr, 
qepA, and oqxAB. The qnr genes have originated in the chromosomes of water-
dwelling or other environmental organisms [85]. The environmental presence of qnr 
gene cassette on qac-containing integrons can contribute to the emergence of FQ 
resistance. Genes qnrA, qnrB, qnrC, qnrD, qnrS, and qnrVC code for proteins of the 
pentapeptide repeat family that protects DNA gyrase and topoisomerase IV from 
quinolone inhibition. Data from a recent structural analysis of a Qnr protein suggest 
that resistance to FQ is achieved by the binding of Qnr protein to topoisomerase, 
which physically prevents the intercalation of the antibiotic [86]. The qnr genes 
generally confer modest protection against FQ [87,88]. The gene aac(60)-lb-cr 
confers decreased susceptibility to CIP and NOR by acetylating the amino nitrogen 
on the piperazinyl substituent present in these drugs [87,88].The oqxAB and qepAB 
genes encode efflux systems transporters that can export FQ molecules. Carriage of 
these genes again confers modest increases in FQ MICs [89]. The 3′CS of class 1 
integrons contained qacED1 and sul1, which mediate low-level resistance to QAC: 
qacED1 encodes an efflux pump belonging to the small multidrug resistance family 
(SMR) and to sulfamethoxazole (sul1) [90-92]. Zou et al. [93] showed that the qac 
and sugE(p) genes were highly associated with FQ resistance among E. coli isolated 
from retail meats.  
Unfortunately, only a few data are available about clinical examples of where 
quinolone resistance is clearly related to QAC use. In clinical E. coli isolates, Buffet-
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Bataillon et al. [48,92] demonstrated an epidemiological relationship between higher 
MIC values of QACs and antibiotic resistance, involving AcrAB-TolC system and 
class 1 integrons. They observed the presence of dfrA/sul1 and qacEΔ1 gene 
cassettes correlated with resistance to co-trimoxazole and high MICs of QACs, with 
overexpression of tolC, marOR and soxS. Use of an inhibitor of efflux pumps reduced 
the MICs of ciprofloxacin and QACs, suggesting that extrusion of CIP and QACs from 
bacteria depends on the AcrAB-TolC system. Sidhu et al. [94] studied 61 strains of S. 
aureus and 177 coagulase-negative staphylococcal strains, isolated from the blood of 
patients with bloodstream infections and from the skin of both children under cancer 
treatment and human immunodeficiency virus-infected patients. The MIC analyses 
revealed that 118 isolates (50%) were resistant to QAC-based disinfectant BC. The 
frequencies of resistance to a range of antibiotics, including CIP, were significantly 
higher among BC-resistant staphylococci than among BC-sensitive staphylococci. 
Only qacA/B and blaZ probes where tested (they hybridized to the same plasmid in 
19 (24%) staphylococcal strains), but the higher frequency of antibiotic resistance 
among BC-resistant strains indicates that the presence of either resistance 
determinant selects for the other during antimicrobial therapy and disinfection in 
hospitals. 
 
 Conclusions 
Resistance to FQ is mainly related to antibiotic use and misuse [95], but the 
evidence presented above could potentially be applicable to other antimicrobial 
agents, sharing the same resistance and survival mechanisms. We may have 
underestimated the effects of non-antibiotic antimicrobials, such as QAC, with an 
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extensive use in biocidal products [9,96]. The observations listed in this review 
support that various mechanisms of resistance that may contribute to cross-
resistance between biocide and antibiotics, including overexpression of efflux pumps, 
biofilm formation, and spontaneous mutations [16,53]. Concerning the use of QAC 
some of the evidence between QAC exposure and resistance to FQ can be 
circumstantial and more clinical studies are needed to confirm or not QAC role in 
triggering antibiotic resistance. The overexpression of efflux pumps facilitates the 
horizontal transfer of mobile genetic elements carrying FQ resistance determinants 
(qnr, aac(60)-Ib-cr, oqxAB, qepAB) in Class 1 integrons (QacED1). However, there 
remain important gaps in our understanding of the mechanisms involved: Clinical 
studies are warranted to validate the in vitro experiments, and decipher the impact of 
QAC use on antimicrobial resistance, including to FQ, in patients and in the 
environment. 
 
 Future perspective 
In Europe, the Biocidal Product Regulation (No 528/2012) [8] is now requiring 
that manufacturers provide evidence that their biocidal products will not promote 
antimicrobial resistance. In the US, the Food and Drug Administration recently 
required manufacturers of antimicrobial hand wash to provide evidence that their 
products had no effect on the emergence of bacterial resistance to antimicrobials [84]. 
Although there are no standard to measure the impact of increasing use of biocidal 
products on the emergence of microbial resistance, Knapp et al. [97] developed such 
a test and validated its use with biocide and biocidal products. However, the 
proposed test does not investigate the effect of biocide usage and gene transfer.  
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Understanding the origins, evolution, and mechanisms of transfer of resistance 
elements is important for our ability to adequately address this public health issue.  
 
EXECUTIVE SUMMARY 
Quaternary Ammonium Compounds (QAC) 
 Over the past decade there has been a dramatic increase in the use of QAC 
and their fields of application. 
 The European Biocidal Product Regulation requires evidence of the possible 
effect of biocide on developing resistance and cross-resistance in bacteria. 
Fluoroquinolones (FQ) 
 
 Multidrug resistance and decreased susceptibility to FQ are now widespread 
 FQ is viewed as one of the highest priority for risk analysis by WHO.  
 
QAC and Efflux pumps and FQ-resistance in bacteria 
 
QAC induce the overexpression of efflux pumps that could potentially lead to:  
 i) a cross-resistance of QAC and FQ mediated by multidrug efflux pumps,  
 ii) a stress response that triggers mutation in the quinolone resistance-
determining region (QRDR), that is only supported by some solid scientific 
evidence to date. 
 iii) increasing the number of persisters in biofilm, and facilitating the transfer of 
mobile genetic elements carrying FQ or QAC resistance determinants.  
 
 
 
References  
Papers of special note have been highlighted as: 
• of interest 
 Future Microbiology 
Peer Review Paper 
 
 16 
 
1. Gerba CP. Quaternary ammonium biocides: efficacy in application. Appl. 
Environ. Microbiol., 81(2), 464-469 (2015). 
 This article reports the uses of different QAC and the structure-activity 
relationship of these products, with evolution in their effectiveness and 
expansion of applications 
2. Merianos JJ. Quaternary ammonium antimicrobial compounds. In: Block SS, 
editor. Disinfection, sterilization, and preservation., 4th ed. Philadelphia, 225-
255 (1991). 
3. Walker EB. Quaternary ammonium compounds. In: Paulson D, editor. 
Handbook of topical antimicrobials: industrial applications in consumer 
products and pharmaceuticals, New York, NY: Marcel Dekker, 99–116 (2003). 
4. Gilbert P, Moore LE. Cationic antiseptics: diversity of action under a common 
epithet. J. Appl. Microbiol., 99(4), 703-715 (2005). 
5. Xue Y, Hieda Y, Kimura K, Takayama K, Fujihara J, Tsujino Y. Kinetic 
characteristics and toxic effects of benzalkonium chloride following 
intravascular and oral administration in rats. J. Chromatogr. B Analyt. Technol. 
Biomed. Life Sci., 811(1), 53-58 (2004). 
6. Clara M, Scharf S, Scheffknecht C, Gans O. Occurrence of selected 
surfactants in untreated and treated sewage. Water Res., 41(19), 4339-4348 
(2007). 
7. Sutterlin H, Alexy R, Coker A, Kummerer K. Mixtures of quaternary ammonium 
compounds and anionic organic compounds in the aquatic environment: 
Elimination and biodegradability in the closed bottle test monitored by LC-
MS/MS. Chemosphere, 72(3), 479-484 (2008). 
8. Biocidal Product Regulation. http://eur-lex.europa.eu/legal-
content/EN/TXT/PDF/?uri=CELEX:02012R0528-20140425&from=EN. 
(accessed June 2015). 
9. SCENIHR 2009. 
http://ec.europa.eu/health/ph_risk/committees/04_scenihr/docs/scenihr_o_021
.pdf (accessed June 2005). 
10. Maillard JY, Bloomfield S, Coelho JR et al. Does microbicide use in consumer 
products promote antimicrobial resistance? A critical review and 
recommendations for a cohesive approach to risk assessment. Microb. Drug. 
Resist., 19(5), 344-354 (2013). 
 This work makes specific recommendations for harmonization of key terms 
and refinement/standardization of methods for testing microbicide resistance 
to better assess the impact and possible links with cross resistance to 
antibiotics. 
11. Lesher GY, Froelich EJ, Gruett MD, Bailey JH, Brundage RP. 1,8-
Naphthyridine Derivatives. A New Class of Chemotherapeutic Agents. J. Med. 
Pharm. Chem., 91, 1063-1065 (1962). 
12. Ball P. Quinolone generations: natural history or natural selection? J. 
Antimicrob. Chemother., 46 Suppl T1, 17-24 (2000). 
13. Hooper DC. Mechanisms of action of antimicrobials: focus on fluoroquinolones. 
Clin. Infect. Dis., 32 Suppl 1, S9-S15 (2001). 
 Future Microbiology 
Peer Review Paper 
 
 17 
14. Pruss GJ, Franco RJ, Chevalier SG, Manes SH, Drlica K. Effects of DNA 
gyrase inhibitors in Escherichia coli topoisomerase I mutants. J. Bacteriol., 
168(1), 276-282 (1986). 
15. Drlica K. Bacterial topoisomerases and the control of DNA supercoiling. 
Trends Genet., 6(12), 433-437 (1990). 
16. Hooper DC. New uses for new and old quinolones and the challenge of 
resistance. Clin. Infect. Dis., 30(2), 243-254 (2000). 
17. Ruiz J, Pons MJ, Gomes C. Transferable mechanisms of quinolone resistance. 
Int. J. Antimicrob. Agents, 40(3), 196-203 (2012). 
18. Putman M, van Veen HW, Konings WN. Molecular properties of bacterial 
multidrug transporters. Microbiol. Mol. Biol. Rev., 64(4), 672-693 (2000). 
19. Soto SM. Role of efflux pumps in the antibiotic resistance of bacteria 
embedded in a biofilm. Virulence, 4(3), 223-229 (2013). 
20. Li XZ, Zhang L, Poole K. Interplay between the MexA-MexB-OprM multidrug 
efflux system and the outer membrane barrier in the multiple antibiotic 
resistance of Pseudomonas aeruginosa. J. Antimicrob. Chemother., 45(4), 
433-436 (2000). 
21. Poole K. Efflux pumps as antimicrobial resistance mechanisms. Ann Med, 
39(3), 162-176 (2007). 
22. Ruiz J. Mechanisms of resistance to quinolones: target alterations, decreased 
accumulation and DNA gyrase protection. J. Antimicrob. Chemother., 51(5), 
1109-1117 (2003). 
23. Laskaris P, Tolba S, Calvo-Bado L, Wellington EM. Coevolution of antibiotic 
production and counter-resistance in soil bacteria. Environ. Microbiol., 12(3), 
783-796 (2010). 
24. Tezel U, Pavlostathis SG. Quaternary ammonium disinfectants: microbial 
adaptation, degradation and ecology. Curr. Opin. Biotechnol., 33, 296-304 
(2015). 
 This review describe efflux determinants conferring QAC resistance, propose 
a phylogenetic classification of QAC-degrading bacterial isolates and postulate 
that resistance to QACs potentially leads to antibiotic resistance and 
proliferation 
25. Wellington EM, Boxall AB, Cross P et al. The role of the natural environment in 
the emergence of antibiotic resistance in gram-negative bacteria. Lancet Infect. 
Dis., 13(2), 155-165 (2013). 
26. Collis CM, Hall RM. Expression of antibiotic resistance genes in the integrated 
cassettes of integrons. Antimicrob. Agents Chemother., 39(1), 155-162 (1995). 
27. Lautenbach E, Strom BL, Bilker WB, Patel JB, Edelstein PH, Fishman NO. 
Epidemiological investigation of fluoroquinolone resistance in infections due to 
extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella 
pneumoniae. Clin. Infect. Dis., 33(8), 1288-1294 (2001). 
28. Neuhauser MM, Weinstein RA, Rydman R, Danziger LH, Karam G, Quinn JP. 
Antibiotic resistance among gram-negative bacilli in US intensive care units: 
implications for fluoroquinolone use. JAMA, 289(7), 885-888 (2003). 
29. WHO. Critically important antimicrobials for human medicine. 3rd revision, 
2011, http://www.who.int/foodborne_disease/resistance/cia/ en (accessed Nov 
1st, 2013). 
 Future Microbiology 
Peer Review Paper 
 
 18 
30. Pagedar A, Singh J, Batish VK. Efflux mediated adaptive and cross resistance 
to ciprofloxacin and benzalkonium chloride in Pseudomonas aeruginosa of 
dairy origin. J. Basic Microbiol., 51(3), 289-295 (2011). 
31. Ricci V, Busby SJ, Piddock LJ. Regulation of RamA by RamR in Salmonella 
enterica serovar Typhimurium: isolation of a RamR superrepressor. Antimicrob. 
Agents Chemother., 56(11), 6037-6040 (2012). 
32. Ricci V, Blair JM, Piddock LJ. RamA, which controls expression of the MDR 
efflux pump AcrAB-TolC, is regulated by the Lon protease. J. Antimicrob. 
Chemother., 69(3), 643-650 (2014). 
33. Morita Y, Cao L, Gould VC, Avison MB, Poole K. nalD encodes a second 
repressor of the mexAB-oprM multidrug efflux operon of Pseudomonas 
aeruginosa. J. Bacteriol., 188(24), 8649-8654 (2006). 
34. Olliver A, Valle M, Chaslus-Dancla E, Cloeckaert A. Role of an acrR mutation 
in multidrug resistance of in vitro-selected fluoroquinolone-resistant mutants of 
Salmonella enterica serovar Typhimurium. FEMS Microbiol. Lett., 238(1), 267-
272 (2004). 
35. Webber MA, Talukder A, Piddock LJ. Contribution of mutation at amino acid 
45 of AcrR to acrB expression and ciprofloxacin resistance in clinical and 
veterinary Escherichia coli isolates. Antimicrob. Agents Chemother., 49(10), 
4390-4392 (2005). 
36. Warner DM, Shafer WM, Jerse AE. Clinically relevant mutations that cause 
derepression of the Neisseria gonorrhoeae MtrC-MtrD-MtrE Efflux pump 
system confer different levels of antimicrobial resistance and in vivo fitness. 
Mol. Microbiol., 70(2), 462-478 (2008). 
37. Oethinger M, Podglajen I, Kern WV, Levy SB. Overexpression of the marA or 
soxS regulatory gene in clinical topoisomerase mutants of Escherichia coli. 
Antimicrob. Agents Chemother., 42(8), 2089-2094 (1998). 
38. Oethinger M, Kern WV, Jellen-Ritter AS, McMurry LM, Levy SB. 
Ineffectiveness of topoisomerase mutations in mediating clinically significant 
fluoroquinolone resistance in Escherichia coli in the absence of the AcrAB 
efflux pump. Antimicrob. Agents Chemother., 44(1), 10-13 (2000). 
39. Ricci V, Peterson ML, Rotschafer JC, Wexler H, Piddock LJ. Role of 
topoisomerase mutations and efflux in fluoroquinolone resistance of 
Bacteroides fragilis clinical isolates and laboratory mutants. Antimicrob. 
Agents Chemother., 48(4), 1344-1346 (2004). 
40. Ricci V, Tzakas P, Buckley A, Piddock LJ. Ciprofloxacin-resistant Salmonella 
enterica serovar Typhimurium strains are difficult to select in the absence of 
AcrB and TolC. Antimicrob. Agents Chemother., 50(1), 38-42 (2006). 
41. Hegstad K, Langsrud S, Lunestad BT, Scheie AA, Sunde M, Yazdankhah SP. 
Does the wide use of quaternary ammonium compounds enhance the 
selection and spread of antimicrobial resistance and thus threaten our health? 
Microb. Drug. Resist., 16(2), 91-104 (2010). 
42. Schweizer HP. Efflux as a mechanism of resistance to antimicrobials in 
Pseudomonas aeruginosa and related bacteria: unanswered questions. Genet 
Mol. Res., 2(1), 48-62 (2003). 
43. Piddock LJ. Clinically relevant chromosomally encoded multidrug resistance 
efflux pumps in bacteria. Clin. Microbiol. Rev., 19(2), 382-402 (2006). 
44. Costa SS, Viveiros M, Amaral L, Couto I. Multidrug Efflux Pumps in 
Staphylococcus aureus: an Update. Open Microbiol. J., 7, 59-71 (2013). 
 Future Microbiology 
Peer Review Paper 
 
 19 
45. Kumar S, Mukherjee MM, Varela MF. Modulation of Bacterial Multidrug 
Resistance Efflux Pumps of the Major Facilitator Superfamily. Int. J. Bacteriol., 
2013 (2013). 
46. Venter H, Mowla R, Ohene-Agyei T, Ma S. RND-type drug efflux pumps from 
Gram-negative bacteria: molecular mechanism and inhibition. Front. Microbiol., 
6, 377 (2015). 
 These data described the methodologies for measuring eﬄux pump inhibition, 
could allow the design, and subsequent experimental verification of potential 
eﬄux pump inhibitors (EPIs). They explored new compounds that could 
reverse drug resistance in Gram-negative pathogens. 
47. Wassenaar TM, Ussery D, Nielsen LN, Ingmer H. Review and phylogenetic 
analysis of qac genes that reduce susceptibility to quaternary ammonium 
compounds in Staphylococcus species. Eur. J. Microbiol. Immunol. (Bp), 5(1), 
44-61 (2015). 
 The aim of this study was to list the qac genes in staphylococci, belonging to 
Major Facilitator Superfamily (MFS) and Small Multidrug Resistance (SMR) 
families. Despite their resemblance in substrate specificity, the Qac proteins 
have little in common, and a number of phylogenetic trees of SMR Qac 
proteins are presented. 
48. Buffet-Bataillon S, Le Jeune A, Le Gall-David S, Bonnaure-Mallet M, Jolivet-
Gougeon A. Molecular mechanisms of higher MICs of antibiotics and 
quaternary ammonium compounds for Escherichia coli isolated from 
bacteraemia. J. Antimicrob. Chemother., 67(12), 2837-2842 (2012). 
 This review describe efflux determinants conferring QAC resistance, propose 
a phylogenetic classification of QAC-degrading bacterial isolates and postulate 
that resistance to QACs potentially leads to antibiotic resistance and 
proliferation 
49. Morita Y, Murata T, Mima T et al. Induction of mexCD-oprJ operon for a 
multidrug efflux pump by disinfectants in wild-type Pseudomonas aeruginosa 
PAO1. J. Antimicrob. Chemother., 51(4), 991-994 (2003). 
50. He GX, Kuroda T, Mima T, Morita Y, Mizushima T, Tsuchiya T. An H(+)-
coupled multidrug efflux pump, PmpM, a member of the MATE family of 
transporters, from Pseudomonas aeruginosa. J. Bacteriol., 186(1), 262-265 
(2004). 
51. Maseda H, Hashida Y, Konaka R, Shirai A, Kourai H. Mutational upregulation 
of a resistance-nodulation-cell division-type multidrug efflux pump, SdeAB, 
upon exposure to a biocide, cetylpyridinium chloride, and antibiotic resistance 
in Serratia marcescens. Antimicrob. Agents Chemother., 53(12), 5230-5235 
(2009). 
52. Rushton L, Sass A, Baldwin A, Dowson CG, Donoghue D, Mahenthiralingam 
E. Key role for efflux in the preservative susceptibility and adaptive resistance 
of Burkholderia cepacia complex bacteria. Antimicrob. Agents Chemother., 
57(7), 2972-2980 (2013). 
53. Morita Y, Tomida J, Kawamura Y. Responses of Pseudomonas aeruginosa to 
antimicrobials. Front. Microbiol., 4, 422 (2014). 
54. Webber MA, Whitehead RN, Mount M, Loman NJ, Pallen MJ, Piddock LJ. 
Parallel evolutionary pathways to antibiotic resistance selected by biocide 
exposure. J. Antimicrob. Chemother., 70(8), 2241-2248 (2015). 
 Future Microbiology 
Peer Review Paper 
 
 20 
55. Rakic-Martinez M, Drevets DA, Dutta V, Katic V, Kathariou S. Listeria 
monocytogenes strains selected on ciprofloxacin or the disinfectant 
benzalkonium chloride exhibit reduced susceptibility to ciprofloxacin, 
gentamicin, benzalkonium chloride, and other toxic compounds. Appl. Environ. 
Microbiol., 77(24), 8714-8721 (2011). 
56. Zhang M, O'Donoghue MM, Ito T, Hiramatsu K, Boost MV. Prevalence of 
antiseptic-resistance genes in Staphylococcus aureus and coagulase-negative 
staphylococci colonising nurses and the general population in Hong Kong. J. 
Hosp. Infect., 78(2), 113-117 (2011). 
57. Furi L, Ciusa ML, Knight D et al. Evaluation of reduced susceptibility to 
quaternary ammonium compounds and bisbiguanides in clinical isolates and 
laboratory-generated mutants of Staphylococcus aureus. Antimicrob. Agents 
Chemother., 57(8), 3488-3497 (2013). 
58. Drlica K. Mechanism of fluoroquinolone action. Curr. Opin. Microbiol., 2(5), 
504-508 (1999). 
59. Drlica K, Hiasa H, Kerns R, Malik M, Mustaev A, Zhao X. Quinolones: action 
and resistance updated. Curr. Top. Med. Chem., 9(11), 981-998 (2009). 
60. Yoshida H, Bogaki M, Nakamura M, Nakamura S. Quinolone resistance-
determining region in the DNA gyrase gyrA gene of Escherichia coli. 
Antimicrob. Agents Chemother., 34(6), 1271-1272 (1990). 
61. Yoshida H, Bogaki M, Nakamura M, Yamanaka LM, Nakamura S. Quinolone 
resistance-determining region in the DNA gyrase gyrB gene of Escherichia coli. 
Antimicrob. Agents Chemother., 35(8), 1647-1650 (1991). 
62. Piddock LJ. Mechanisms of fluoroquinolone resistance: an update 1994-1998. 
Drugs, 58 Suppl 2, 11-18 (1999). 
63. Zgur-Bertok D. DNA damage repair and bacterial pathogens. PLoS Pathog., 
9(11), e1003711 (2013). 
64. Baharoglu Z, Mazel D. SOS, the formidable strategy of bacteria against 
aggressions. FEMS Microbiol. Rev., 38(6), 1126-1145 (2014). 
65. Ceragioli M, Mols M, Moezelaar R, Ghelardi E, Senesi S, Abee T. 
Comparative transcriptomic and phenotypic analysis of the responses of 
Bacillus cereus to various disinfectant treatments. Appl. Environ. Microbiol., 
76(10), 3352-3360 (2010). 
66. Poole K. Bacterial stress responses as determinants of antimicrobial 
resistance. J. Antimicrob. Chemother., 67(9), 2069-2089 (2012). 
67. Mc Cay PH, Ocampo-Sosa AA, Fleming GT. Effect of subinhibitory 
concentrations of benzalkonium chloride on the competitiveness of 
Pseudomonas aeruginosa grown in continuous culture. Microbiology, 156(Pt 
1), 30-38 (2010). 
68. Pagedar A, Singh J, Batish VK. Adaptation to benzalkonium chloride and 
ciprofloxacin affects biofilm formation potential, efflux pump and haemolysin 
activity of Escherichia coli of dairy origin. J. Dairy Res., 79(4), 383-389 (2012). 
69. Baugh S, Phillips CR, Ekanayaka AS, Piddock LJ, Webber MA. Inhibition of 
multidrug efflux as a strategy to prevent biofilm formation. J. Antimicrob. 
Chemother., 69(3), 673-681 (2014). 
70. Jolivet-Gougeon A, Bonnaure-Mallet M. Biofilms as a mechanism of bacterial 
resistance. Drug Discov. Today Technol., 11, 49-56 (2014). 
 Future Microbiology 
Peer Review Paper 
 
 21 
71. Ebrahimi A, Hemati M, Shabanpour Z et al. Effects of benzalkonium chloride 
on planktonic growth and biofilm formation by animal bacterial pathogens. 
Jundishapur J. Microbiol., 8(2), e16058 (2015). 
72. Ortiz S, Lopez V, Martinez-Suarez JV. The influence of subminimal inhibitory 
concentrations of benzalkonium chloride on biofilm formation by Listeria 
monocytogenes. Int. J. Food Microbiol., 189, 106-112 (2014). 
73. Wood TK, Knabel SJ, Kwan BW. Bacterial persister cell formation and 
dormancy. Appl. Environ. Microbiol., 79(23), 7116-7121 (2013). 
74. Lewis K. Persister cells. Annu Rev Microbiol, 64, 357-372 (2010). 
75. Madsen JS, Burmolle M, Hansen LH, Sorensen SJ. The interconnection 
between biofilm formation and horizontal gene transfer. FEMS Immunol. Med. 
Microbiol., 65(2), 183-195 (2012). 
76. Gillings MR, Holley MP, Stokes HW. Evidence for dynamic exchange of qac 
gene cassettes between class 1 integrons and other integrons in freshwater 
biofilms. FEMS Microbiol. Lett., 296(2), 282-288 (2009). 
77. Baharoglu Z, Bikard D, Mazel D. Conjugative DNA transfer induces the 
bacterial SOS response and promotes antibiotic resistance development 
through integron activation. PLoS Genet., 6(10), e1001165 (2010). 
78. Baharoglu Z, Krin E, Mazel D. Connecting environment and genome plasticity 
in the characterization of transformation-induced SOS regulation and carbon 
catabolite control of the Vibrio cholerae integron integrase. J. Bacteriol., 194(7), 
1659-1667 (2012). 
79. van der Veen S, Abee T. Dependence of continuous-flow biofilm formation by 
Listeria monocytogenes EGD-e on SOS response factor YneA. Appl. Environ. 
Microbiol., 76(6), 1992-1995 (2010). 
80. Hocquet D, Llanes C, Thouverez M et al. Evidence for induction of integron-
based antibiotic resistance by the SOS response in a clinical setting. PLoS 
Pathog., 8(6), e1002778 (2012). 
81. Gaze WH, Abdouslam N, Hawkey PM, Wellington EM. Incidence of class 1 
integrons in a quaternary ammonium compound-polluted environment. 
Antimicrob. Agents Chemother., 49(5), 1802-1807 (2005). 
82. Gaze WH, Zhang L, Abdouslam NA et al. Impacts of anthropogenic activity on 
the ecology of class 1 integrons and integron-associated genes in the 
environment. ISME J., 5(8), 1253-1261 (2011). 
83. Guerin E, Cambray G, Sanchez-Alberola N et al. The SOS response controls 
integron recombination. Science, 324(5930), 1034 (2009). 
84. Gaze WH, Krone SM, Larsson DG et al. Influence of humans on evolution and 
mobilization of environmental antibiotic resistome. Emerg. Infect. Dis., 19(7) 
(2013). 
85. Xiong X, Bromley EH, Oelschlaeger P, Woolfson DN, Spencer J. Structural 
insights into quinolone antibiotic resistance mediated by pentapeptide repeat 
proteins: conserved surface loops direct the activity of a Qnr protein from a 
gram-negative bacterium. Nucleic Acids Res., 39(9), 3917-3927 (2011). 
86. Jacoby G, Cattoir V, Hooper D et al. qnr Gene nomenclature. Antimicrob. 
Agents Chemother., 52(7), 2297-2299 (2008). 
87. Robicsek A, Jacoby GA, Hooper DC. The worldwide emergence of plasmid-
mediated quinolone resistance. Lancet Infect. Dis., 6(10), 629-640 (2006). 
88. Martinez-Martinez L, Pascual A, Jacoby GA. Quinolone resistance from a 
transferable plasmid. Lancet, 351(9105), 797-799 (1998). 
 Future Microbiology 
Peer Review Paper 
 
 22 
89. Strahilevitz J, Jacoby GA, Hooper DC, Robicsek A. Plasmid-mediated 
quinolone resistance: a multifaceted threat. Clin. Microbiol. Rev., 22(4), 664-
689 (2009). 
90. Paulsen IT, Littlejohn TG, Radstrom P et al. The 3' conserved segment of 
integrons contains a gene associated with multidrug resistance to antiseptics 
and disinfectants. Antimicrob. Agents Chemother., 37(4), 761-768 (1993). 
91. Yong D, Toleman MA, Giske CG et al. Characterization of a new metallo-beta-
lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried 
on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from 
India. Antimicrob. Agents Chemother., 53(12), 5046-5054 (2009). 
92. Buffet-Bataillon S, Branger B, Cormier M, Bonnaure-Mallet M, Jolivet-
Gougeon A. Effect of higher minimum inhibitory concentrations of quaternary 
ammonium compounds in clinical E. coli isolates on antibiotic susceptibilities 
and clinical outcomes. J. Hosp. Infect., 79(2), 141-146 (2011). 
93. Zou L, Meng J, McDermott PF et al. Presence of disinfectant resistance genes 
in Escherichia coli isolated from retail meats in the USA. J. Antimicrob. 
Chemother., 69(10), 2644-2649 (2014). 
94. Sidhu MS, Heir E, Leegaard T, Wiger K, Holck A. Frequency of disinfectant 
resistance genes and genetic linkage with beta-lactamase transposon Tn552 
among clinical staphylococci. Antimicrob. Agents Chemother., 46(9), 2797-
2803 (2002). 
95. Hughes D. Selection and evolution of resistance to antimicrobial drugs. IUBMB 
Life, 66(8), 521-529 (2014). 
96. SCENIHR 2010. 
http://ec.europa.eu/health/scientific_committees/emerging/docs/scenihr_o_028
.pdf (accessed June 2015). 
97. Knapp L, Amezquita A, McClure P, Stewart S, Maillard JY. Development of a 
protocol for predicting bacterial resistance to microbicides. Appl. Environ. 
Microbiol., 81(8), 2652-2659 (2015). 
  
  
 Future Microbiology 
Peer Review Paper 
 
 23 
Figure and Table legends 
 
Figure 1: Summary of the impact of quaternary ammonium compounds (QAC) use 
on resistance to fluoroquinolones. *QRDR: quinolone resistance-determining region. 
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Figure 2. Schematic illustration of the main types of multidrug-resistance efflux 
pumps (MDR) involved in extrusion of QAC and quinolones in a) Gram positive and 
b) Gram-negative bacteria [24,42-47]. Hatched: the efflux pumps encoded by plasmid 
genes 
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Table 1: Fields of quaternary ammonium compounds (QAC) use [3,4]. 
Preservatives in pharmaceutical and cosmetic products : Eyewash/artificial tears, 
nose decongestant lotions, facial cleansers, acne treatment, sun protection 
creams and lotions, baby lotions, moisturisers, pain relief poultices or creams, 
hair conditioners, hair colour and styling products, make-up and make-up removal 
products, and hand sanitizers 
Supplement in commercially available alcohol-based hand rubs, which contain 
mainly ethanol, isopropanol or n-propanol, as well as in mouthwashes. 
Benzalkonium chloride  
Cleaning and disinfecting farm buildings : poultry buildings (hatcheries), poultry 
cages, poultry house premises, poultry feeding equipment, poultry watering 
equipment, poultry equipment, poultry transportation vehicles, animal cages, 
animal living quarters, animal feeding and watering equipment, commercial egg 
treatment, hatchery equipment, incubators, hatchery premises, farm premises, 
agricultural equipment, shoe baths, and poultry processing equipment  
Alkyl dimethyl benzyl ammonium chloride, Didecyl dimethyl ammonium chloride, 
Octyl decyl dimethyl ammonium chloride, Dioctyl dimethyl ammonium chloride 
Decontamination of healthcare devices and environmental surfaces 
Benzalkonium chloride, Didecyl dimethyl ammonium chloride 
Waste water purification 
Benzalkonium chloride 
Antifungal treatment in horticulture 
Benzalkonium chloride 
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Table 2: Different generations and chemical structures of quaternary ammonium 
compounds (QAC). 
Generation quarternaries Description 
 
The QAC are ammonium compounds 
in which four organic groups (R1-4) 
are linked to a nitrogen atom (N) that 
produces a positively charged ion 
(cation). In these QAC, the organic 
radical is the cation, and chlorine is 
usually the anion (X).  
First generation quaternaries 
 
The first generation of QAC are 
alkyldimethylbenzyl-ammonium 
chloride (ADBAC) ie Benzalkonium 
chloride with alkyl chains of 8 to 18 
Carbons (C); Cetalkonium chloride= 
ADBAC with alkyl chains of 16 C; 
Stearalkonium chloride with alkyl 
chains of 18C. 
Second generation quaternaries 
 
The second generation of QAC was 
obtained by substitution of aromatic 
rings in ADBAC by chlorine or alkyl 
distributions to get the products like to 
get the products like 
alkyldimethylethylbenzylammonium 
chloride; Chlorure d'aralkonium (Alkyl 
diméthyl-3, 4-dichlorobenzyl-
ammonium chloride). 
Third generation quaternaries The third generation of QAC are a 
mixture of first and second 
generation, i.e., benzalkonium 
chloride and 
alkyldimethylbenzylammonium 
chloride.  
Fourth generation quaternaries 
 
The Twin Chain QAC with chains that 
are dialkyl linear and without the 
benzene ring are the fourth 
generation of QAC ie dialkyl methyl 
amines as Dioctyl Dimethyl 
Ammonium Chloride, Didecyl 
Dimethyl Ammonium Chloride 
 Future Microbiology 
Peer Review Paper 
 
 28 
(DDAC). 
Fifth generation quaternaries The mixtures of the fourth generation 
(Dialkyl methyl amines) with the first 
generation (alkyl dimethyl benzyl 
ammonium chloride) represents the 
fifth generation 
 
  
 
